NEORISP 1 mg. 30 tablets

WHAT IS AND WHAT NEORISP
The film-coated tablets are available in blister packs of PVC / aluminum foil, packaged in a carton containing patient information leaflet.
Each tablet contains 1 mg of the active ingredient risperidone
Neorisp is indicated for the treatment of a wide range of patients with schizophrenia - a first psychotic episode, recurrent, chronic schizophrenia and other psychotic conditions, in which positive symptoms / as hallucinations, delusions, impaired thinking, hostility, suspiciousness / and / or negative symptoms are bright expressed. Neorisp also alleviates affective symptoms associated with schizophrenia. Furthermore Neorisp is also indicated for long term treatment for the prevention of recurrence in patients with chronic infection.

BEFORE YOU TAKE NEORISP
Do not take the following conditions:
Contraindicated in patients with hypersensitivity to the active substance or to any of the excipients of the tablet.

SPECIAL WARNINGS FOR TREATMENT WITH NEORISP
Due to the alpha-blocking activity of the active ingredient risperidone possible onset of decreased blood pressure when standing up, especially during the initial period of dose adjustment. Neorisp should be used with caution in patients with known cardiovascular disease and the dose should be adjusted gradually, as recommended by your doctor. At the onset of hypotension should consider dose reduction.
The use of classical neuroleptics have been described cases of neuroleptic malignant syndrome, characterized by hyperthermia, muscle rigidity, autonomic instability, altered consciousness and elevated levels of creatine. In this case, all antipsychotic drugs should be stopped.
Attention is also required when prescribing Peopisp of patients with Parkinson's disease, since it is theoretically possible to cause a worsening of the disease.
In studies in elderly patients with dementia treated concomitantly with furosemide and medicinal products containing the active ingredient risperidone, observed higher mortality compared to treatment with only reception of risperidone or self-administration of furosemide.

Pregnancy and lactation
Ask your doctor before taking any medicine.
The safety of risperidone for use during pregnancy etc. and man has not been established. For this reason Neorisp should be used during pregnancy only if the benefit outweighs the risks.
It was found that risperidone are excreted in human milk. Therefore, women taking Neoresp should not breastfeed.

DRIVE AND USE MACHINES
It is Neorisp prevent activities requiring alertness. Therefore, patients should be advised not to drive or operate machines to establish their individual susceptibility.

HOW TO TAKE NEORISP
Always take Neorisp, just as you told your doctor. If you're not sure, ask your doctor. If you're not sure, ask your doctor.
Schizophrenia
Prieminavane from other antipsychotics to Neorisp:
When medically appropriate, recommended phasing previous treatment after initiation of therapy with Neorisp. Also taco, if medically appropriate, is recommended for the patient priminavane of antipsychotic depot preparations, therapy Neorisp begin with replacement of the next scheduled injection. The need for continuing existing anti-Parkinson therapy should be periodically reviewed.
Mature
Neorisp may be administered orally once or twice daily
Patients should begin treatment with a dose of 2 mg / day Neorisp. The dose may be increased on the second day to 4 mg. Thereafter, the dosage can be maintained unchanged or may be individually adjusted, if necessary. Most patients respond to daily doses between 4 and 6 mg. In some patients suitable slower titration phase and a lower starting and maintenance dose.
Doses exceeding 10 mg daily showed no more effective than lower doses and may cause extrapyramidal symptoms. As the safety of doses above 16 mg daily have not been investigated, it should be administered doses exceeding those values.
Elderly
An initial dose of 0.5 mg twice a day. This dose can be individually adjusted with additions of 0.5 mg twice daily to 1-2 mg twice daily.
Children
Lispva experience of use in children below 15 years of age.
Kidney and liver disease
An initial dose of 0.5 mg twice a day. This dose can be individually adjusted with additions of 0.5 mg twice daily to 1-2 mg twice daily.

STORAGE:
Keep at temperatures below 25 ° C. Protect from light and moisture.
Do not use after the expiry date.
Medicines should not be disposed of in wastewater or household waste. Ask your pharmacist how to dispose of your medications. These measures will help to protect the environment.

MORE INFORMATION
What:
- The active ingredient is risperidone
- The other ingredients are corn starch, microcrystalline cellulose, lactose monohydrate, sodium starch glycolate, magnesium stearate.